Lupron PEDS
Drug
AbbVie, Inc.
Total Payments
$20,798
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $20,798 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $20,798 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A10-810 | AbbVie, Inc. | $20,798 | 0 |
Top Doctors Receiving Payments for Lupron PEDS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | La Jolla, CA | $20,798 | 1 |
Ad
Manufacturing Companies
- AbbVie, Inc. $20,798
Product Information
- Type Drug
- Total Payments $20,798
- Total Doctors 0
- Transactions 1
About Lupron PEDS
Lupron PEDS is a drug associated with $20,798 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is AbbVie, Inc..
Payment data is available from 2019 to 2019. In 2019, $20,798 was paid across 1 transactions to 0 doctors.
The most common payment nature for Lupron PEDS is "Unspecified" ($20,798, 100.0% of total).
Lupron PEDS is associated with 1 research study, including "A10-810" ($20,798).